1. Heinemann K et coll., Comparative contraceptive effectiveness of levonorgestrel-releasing and copper intrauterine devices: the European Active Surveillance Study for Intrauterine Devices, Contraception, 2015, 91(4):280–283, http://dx.doi.org/10.1016/j.contraception.2015.01.011.
2. d’Arcangues C, Worldwide use of intrauterine devices for contraception, Contraception, 2007, 75(6, Suppl.):S2–S7, http://dx.doi.org/10.1016/j.contraception.2006.12.024.
3. Organisation mondiale de la Santé (OMS), Critères de recevabilité pour l’adoption et l’utilisation continue de méthodes contraceptives, cinquième édition, 2015, https://www.who.int/reproductivehealth/publications/family_planning/Ex-Summ-MEC-5/fr/.
4. Kaneshiro B et Aeby T, Long-term safety, efficacy and patient acceptability of the intrauterine Copper T-380A contraceptive device, International Journal of Women’s Health, 2010, 2:211–220, http://dx.doi.org/10.2147/IJWH.S6914.
5. Heinemann K et coll., Risk of uterine perforation with levonorgestrel-releasing and copper intrauterine devices in the European Active Surveillance Study on Intrauterine Devices, Contraception, 2015, 91(4):274–279, http://dx.doi.org/10.1016/j.contraception.2015.01.007.
6. Hubacher D, Chen P-L et Park S, Side effects from the copper IUD: Do they decrease over time? Contraception, 2009, 79(5):356–362, http://dx.doi.org/10.1016/j.contraception.2008.11.012.
7. Nations Unies, Département des affaires économiques et sociales, Division de la population, World contraceptive use 2015, https://www.un.org/en/development/desa/population/publications/dataset/contraception/wcu2015.asp.
8. Tsui AO, Brown W et Li Q, Contraceptive practice in Sub-Saharan Africa, Population and Development Review, 2017, 43(Suppl. 1):166–191, https://onlinelibrary.wiley.com/doi/full/10.1111/padr.12051.
9. Nations Unies, Département des affaires économiques et sociales, Division de la population, World contraceptive use 2016, http://www.un.org/en/development/desa/population/publications/dataset/contraception/wcu2016.shtml.
10. Chola L et coll., Scaling up family planning to reduce maternal and child mortality: the potential costs and benefits of modern contraceptive use in South Africa, PLoS One, 2015, 10(6):e0130077, http://dx.doi.org/10.1371/journal.pone.0130077.
11. OMS, Base de données de l’Observatoire mondial de la santé, global survey: medical doctors, 2016, http://apps.who.int/gho/data/node.main.HWFGRP_0020?lang=en.
12. OMS, Base de données de l’Observatoire mondial de la santé: nursing and midwifery personnel, 2019, http://apps.who.int/gho/data/node.main.HWFGRP_0040?lang=en.
13. Goldstuck ND, Reducing barriers to the use of the intrauterine contraceptive device as a long-acting reversible contraceptive, African Journal of Reproductive Health, 2014, 18(4):15–25.
14. Gutin SA et coll., Survey of knowledge, attitudes and practices surrounding the intrauterine device in South Africa, Contraception, 2011, 83(2):145–150, http://dx.doi.org/10.1016/j.contraception.2010.07.009.
15. Twesigye R et coll., Ugandan women’s view of the IUD: generally favorable but many have misperceptions about health risks, Global Health, Science and Practice, 2016, 4(Suppl. 2):S73–S82, http://dx.doi.org/10.9745/GHSP-D-15–00304.
16. Recommandations de l’OMS: Optimisation des rôles du personnel de santé par la délégation des tâches pour améliorer l’accès aux interventions de santé maternelle et néonatale, Genève, OMS: 2012, https://apps.who.int/iris/bitstream/handle/10665/84202/9789242504842_fre.pdf?sequence=1.
17. Statistics South Africa, South Africa Demographic and Health Survey (SADHS), 2016, http://www.statssa.gov.za/?page_id=6634.
18. Family Planning 2020, Zimbabwe, https://www.familyplanning2020.org/zimbabwe.
19. Nurse-midwives insert IUDs in Barbados, IPPF Medical Bulletin, 1967, 1(6):4.
20. Lassner KJ et coll., Comparative study of safety and efficacy of IUD insertions by physicians and nursing personnel in Brazil, Bulletin of the Pan American Health Organization, 1995, 29(3):206–215.
21. Abdool Karim Q et coll., Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women, Science, 2010, 329(5996):1168–1174, http://dx.doi.org/10.1126/science.1193748.
22. Van Damme L et coll., Preexposure prophylaxis for HIV infection among African women, New England Journal of Medicine, 2012, 367(5):411–422, http://dx.doi.org/10.1056/NEJMoa1202614.
23. Marrazzo JM et coll., Tenofovir-based preexposure prophylaxis for HIV infection among African women, New England Journal of Medicine, 2015, 372(6):509–518, http://dx.doi.org/10.1056/NEJMoa1402269.
24. Baeten JM et coll., Use of a vaginal ring containing Dapivirine for HIV-1 prevention in women, New England Journal of Medicine, 2016, 375(22):2121–2132, http://dx.doi.org/10.1056/NEJMoa1506110.
25. National Statistical Office Malawi et ICF, Malawi Demographic and Health Survey 2015–16, Zomba, Malawi, et Rockville, MD, É.-U.: National Statistical Office Malawi et ICF, 2017, https://dhsprogram.com/pubs/pdf/FR319/FR319.pdf.
26. Uganda Bureau of Statistics et ICF, Uganda Demographic and Health Survey 2016, Kampala, Ouganda et Rockville, MD, É.-U.: Uganda Bureau of Statistics et ICF, 2018, https://dhsprogram.com/pubs/pdf/FR333/FR333.pdf.
27. Zimbabwe National Statistics Agency et ICF International, Zimbabwe Demographic and Health Survey 2015: Final Report, Rockville, MD, É.-U.: Zimbabwe National Statistics Agency et ICF International, 2016, https://dhsprogram.com/pubs/pdf/FR322/FR322.pdf.
28. South Africa National Department of Health, Statistics South Africa, South African Medical Research Council et ICF, South Africa Demographic and Health Survey 2016, Pretoria, Afrique du Sud et Rockville, MD, É.-U.: South Africa National Department of Health, Statistics South Africa, South African Medical Research Council et ICF, 2019, https://dhsprogram.com/pubs/pdf/FR337/FR337.pdf.
29. U.S. Department of Health and Human Services, National Institutes of Health, National Institute of Allergy and Infectious Diseases, Division of AIDS, Division of AIDS table for grading the severity of adult and pediatric adverse events, corrected version 2.1, 2017, https://rsc.niaid.nih.gov/sites/default/files/table-for-grading-severity-of-adult-pediatric-adverse-events.pdf.
30. Cason P et Goodman S, Protocol for Provision of Intrauterine Contraception, San Francisco, CA, É.-U.: UCSF Bixby Center for Global Reproductive Health, 2016, http://beyondthepill.ucsf.edu/sites/beyondthepill.ucsf.edu/files/Beyond%20the%20Pill%20IUC%20Protocol.pdf.
31. Goodwin TM et al., eds., Management of Common Problems in Obstetrics and Gynecology, cinquième ed., Oxford, UK: John Wiley & Sons, 2010.
32. Harrison-Woolrych M, Ashton J et Coulter D, Insertion of the Multiload Cu375 intrauterine device; experience in over 16,000 New Zealand women, Contraception, 2002, 66(6):387–391, http://dx.doi.org/10.1016/S0010–7824(02)00413–4.
33. Bahamondes L et al., A 3-year multicentre randomized controlled trial of etonogestrel- and levonorgestrel-releasing contraceptive implants, with non-randomized matched copper-intrauterine device controls, Human Reproduction, 2015, 30(11):2527–2538, http://dx.doi.org/10.1093/humrep/dev221.
34. Akin A, Gray RH et Ramos R, Training auxiliary nurse-midwives to provide IUD services in Turkey and the Philippines, Studies in Family Planning, 1980, 11(5):178–187, http://dx.doi.org/10.2307/1965760.
35. Dervisoglu AA, Can midwives be trained to insert IUDs? Results from Turkey, Entre Nous, 1988, 12:10–12.
36. Madden T et al., Association of age and parity with intrauterine device expulsion, Obstetrics & Gynecology, 2014, 124(4):718–726, http://dx.doi.org/10.1097/AOG.0000000000000475.
37. Diedrich JT et coll., Association of short-term bleeding and cramping patterns with long-acting reversible contraceptive method satisfaction, American Journal of Obstetrics & Gynecology, 2015, 212(1):50.e1–50.e8, http://dx.doi.org/10.1016/j.ajog.2014.07.025.
38. National Institutes of Health, U.S. National Library of Medicine, The evidence for contraceptive options and HIV outcomes trial (ECHO), updated 2019, https://clinicaltrials.gov/ct2/show/NCT02550067.